Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has received approval from the Biomedical Advanced Research and Development Authority ...

🌟 Exciting progress in the fight against COVID-19! Vaxart just got the green light from BARDA to begin dosing 10,000 participants in their Phase 2b trial for an oral pill vaccine.

Innovation like this brings us closer to easier, more accessible protection for all! 💊✨

#MedSky #COVID19 #Vaccines

Aww such a big loss, hope she RIP. Sorry to hear this.

www.nature.com/articles/s41...

“Vaccines have saved 154 million lives globally since the launch of the Expanded Programme on Immunization by the World Health Organization in 1974 and are one of the great triumphs of medicine”

Omg shocking